2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the …
K Zeppenfeld, J Tfelt-Hansen, M De Riva… - European heart …, 2022 - academic.oup.com
4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …
Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic …
A Regueiro, O Abdul-Jawad Altisent… - Circulation …, 2016 - Am Heart Assoc
Background—Available data on the clinical impact of new-onset left bundle branch block
(LBBB) and permanent pacemaker implantation (PPI) after transcatheter aortic valve …
(LBBB) and permanent pacemaker implantation (PPI) after transcatheter aortic valve …
[PDF][PDF] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
PM Elliott, A Anastasakis, MA Borger… - Polish Heart …, 2014 - journals.viamedica.pl
Kardiomiopatie definiuje się jako strukturalne oraz funkcjonalne nieprawidłowości mięśnia
komór, które nie wynikają z niedokrwienia na skutek choroby wieńcowej czy …
komór, które nie wynikają z niedokrwienia na skutek choroby wieńcowej czy …
Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark
RE Kirkfeldt, JB Johansen, EA Nohr… - European heart …, 2014 - academic.oup.com
Aims Complications after cardiac implantable electronic device (CIED) treatment, including
permanent pacemakers (PMs), cardiac resynchronization therapy devices with defibrillators …
permanent pacemakers (PMs), cardiac resynchronization therapy devices with defibrillators …
Accf/hrs/aha/ase/hfsa/scai/scct/scmr 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: A report of the …
AM Russo, RF Stainback, SR Bailey, AE Epstein… - Journal of the American …, 2013 - jacc.org
Abstract The American College of Cardiology Foundation in collaboration with the Heart
Rhythm Society and key specialty and subspecialty societies conducted a review of common …
Rhythm Society and key specialty and subspecialty societies conducted a review of common …
Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and …
LRAO Nordkamp, PG Postema, RE Knops, N van Dijk… - Heart Rhythm, 2016 - Elsevier
Background Implantable cardioverter-defibrillators (ICDs) are implanted with the intention to
prolong life in selected patients with inherited arrhythmia syndromes, but ICD implantation is …
prolong life in selected patients with inherited arrhythmia syndromes, but ICD implantation is …
Ventricular arrhythmias and sudden cardiac death
Management strategies for ventricular arrhythmias are guided by the risk of sudden death
and severity of symptoms. Patients with a substantial risk of sudden death usually need an …
and severity of symptoms. Patients with a substantial risk of sudden death usually need an …
Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function
Background—Very few data exist on the clinical impact of permanent pacemaker
implantation (PPI) after transcatheter aortic valve implantation. The objective of this study …
implantation (PPI) after transcatheter aortic valve implantation. The objective of this study …
Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy
TF Brouwer, D Yilmaz, R Lindeboom, MS Buiten… - Journal of the American …, 2016 - jacc.org
Background: Transvenous implantable cardioverter-defibrillators (TV-ICDs) improve survival
in patients at risk for sudden cardiac death, but complications remain an important …
in patients at risk for sudden cardiac death, but complications remain an important …
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in …
The implantable cardioverter defibrillator (ICD) has emerged as an important treatment
option for selected patients who are at risk of sudden cardiac death. Randomized trials have …
option for selected patients who are at risk of sudden cardiac death. Randomized trials have …